Melanotan II Side Effects: Safety Signals and Warnings
Melanotan II safety concerns are compound-specific. The main listed side effects are Nausea and facial flushing, Darkening of existing moles and nevi, and Fatigue and drowsiness. The main warning signals are Not approved by any regulatory agency for human use, Potential risk of melanoma promotion due to melanocyte stimulation - patients with family history should avoid, and Unregulated products may contain impurities or incorrect dosing.
Direct Answer
Evidence for Melanotan II is too preliminary to support a research protocol with confidence, and its safety profile is a genuine concern - not approved by any regulatory agency, associated with spontaneous erections, blood pressure changes, nausea, and multiple case reports of melanoma in pre-existing nevi. Of the Sexual Health compounds, PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire and has a far superior safety and evidence profile.
- Evidence grade
- Level C
- Research status
- Preclinical
- Category
- Skin & Beauty
- Best for
- No validated therapeutic application - melanocortin receptor pharmacology research (with caution)
Reported Side Effects
- Nausea and facial flushing
- Darkening of existing moles and nevi
- Fatigue and drowsiness
- Spontaneous erections
- Elevated blood pressure
- Injection site reactions
Warnings
- Not approved by any regulatory agency for human use
- Potential risk of melanoma promotion due to melanocyte stimulation - patients with family history should avoid
- Unregulated products may contain impurities or incorrect dosing
- Cardiovascular side effects including hypertension reported
- Long-term safety data in humans is lacking
Known or Plausible Interactions
- Antihypertensive medications (may counteract blood pressure effects)
- PDE5 inhibitors such as sildenafil (additive risk of priapism)
- Immunosuppressants (unknown interaction with melanocyte activity)
Regulatory Context
Not FDA-approved. Classified as an unscheduled research peptide in the United States. Banned for sale as a consumer product in many countries including Australia and the UK. Prohibited by WADA in competitive sports.
Evidence Snapshot
| Evidence grade | Level C |
|---|---|
| Research status | Preclinical |
| Best supported outcomes | Skin Pigmentation (Level C), Erectile Function (Level C), and Nausea & Side Effects (Level C) |
| Primary citation count | 3 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "Melanotan II Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/melanotan-ii-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.